DAVITA INC. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
DAVITA INC. (DVA) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $77.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2026-08-04
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2026-06-30 was $77.83M, a 2.56% increase year-over-year.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2026-03-31 was $77.50M, a 11.84% increase year-over-year.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2025-12-31 was $96.81M, a 7.67% increase year-over-year.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2025-09-30 was $89.92M, a 10.91% increase year-over-year.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2025 was $331.91M, a 5.57% increase from fiscal 2024.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2024 was $314.39M, a 18.44% increase from fiscal 2023.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2023 was $265.44M, a 19.98% increase from fiscal 2022.
- DAVITA INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2022 was $221.24M, a 5.17% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $77.83M 10-Q · filed 2026-08-04 | $155.33M 10-Q · filed 2026-08-04 | $252.15M derived: sum of 3 quarters · filed 2026-08-04 | $342.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $77.50M 10-Q · filed 2026-05-05 | $174.32M derived: sum of 2 quarters · filed 2026-05-05 | $264.24M derived: sum of 3 quarters · filed 2026-05-05 | $340.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $96.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $186.73M derived: sum of 2 quarters · filed 2026-02-11 | $262.61M derived: sum of 3 quarters · filed 2026-08-04 | $331.91M 10-K · filed 2026-02-11 |
| 2025-09-30 | $89.92M 10-Q · filed 2025-10-29 | $165.80M derived: sum of 2 quarters · filed 2026-08-04 | $235.10M 10-Q · filed 2025-10-29 | $325.01M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $75.88M 10-Q · filed 2026-08-04 | $145.18M 10-Q · filed 2026-08-04 | $235.10M derived: sum of 3 quarters · filed 2026-08-04 | $316.17M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $69.30M 10-Q · filed 2026-05-05 | $159.22M derived: sum of 2 quarters · filed 2026-05-05 | $240.29M derived: sum of 3 quarters · filed 2026-05-05 | $317.36M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $89.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $170.99M derived: sum of 2 quarters · filed 2026-02-11 | $248.06M derived: sum of 3 quarters · filed 2026-02-11 | $314.39M 10-K · filed 2026-02-11 |
| 2024-09-30 | $81.07M 10-Q · filed 2025-10-29 | $158.15M derived: sum of 2 quarters · filed 2025-10-29 | $224.48M 10-Q · filed 2025-10-29 | $304.39M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $77.08M 10-Q · filed 2025-08-05 | $143.41M 10-Q · filed 2025-08-05 | $223.31M derived: sum of 3 quarters · filed 2026-02-11 | $286.04M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $66.33M 10-Q · filed 2025-05-12 | $146.24M derived: sum of 2 quarters · filed 2026-02-11 | $208.97M derived: sum of 3 quarters · filed 2026-02-11 | $276.65M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $79.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $142.64M derived: sum of 2 quarters · filed 2026-02-11 | $210.32M derived: sum of 3 quarters · filed 2026-02-11 | $265.44M 10-K · filed 2026-02-11 |
| 2023-09-30 | $62.73M 10-Q · filed 2024-10-29 | $130.41M derived: sum of 2 quarters · filed 2024-10-29 | $185.54M 10-Q · filed 2024-10-29 | $244.05M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $67.69M 10-Q · filed 2024-08-06 | $122.81M 10-Q · filed 2024-08-06 | $181.32M derived: sum of 3 quarters · filed 2025-02-13 | $240.65M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $55.12M 10-Q · filed 2024-05-02 | $113.63M derived: sum of 2 quarters · filed 2025-02-13 | $172.96M derived: sum of 3 quarters · filed 2025-02-13 | $232.77M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $58.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $117.84M derived: sum of 2 quarters · filed 2025-02-13 | $177.65M derived: sum of 3 quarters · filed 2025-02-13 | $221.24M 10-K · filed 2025-02-13 |
| 2022-09-30 | $59.33M 10-Q · filed 2023-11-07 | $119.14M derived: sum of 2 quarters · filed 2023-11-07 | $162.73M 10-Q · filed 2023-11-07 | $224.69M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $59.81M 10-Q · filed 2023-08-03 | $103.40M 10-Q · filed 2023-08-03 | $165.36M derived: sum of 3 quarters · filed 2024-02-14 | $225.36M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $43.60M 10-Q · filed 2023-05-08 | $105.56M derived: sum of 2 quarters · filed 2024-02-14 | $165.56M derived: sum of 3 quarters · filed 2024-02-14 | $222.77M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $61.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $121.96M derived: sum of 2 quarters · filed 2024-02-14 | $179.17M derived: sum of 3 quarters · filed 2024-02-14 | $233.31M 10-K · filed 2024-02-14 |
| 2021-09-30 | $60.00M 10-Q · filed 2022-10-31 | $117.21M derived: sum of 2 quarters · filed 2022-10-31 | $171.35M 10-Q · filed 2022-10-31 | $231.95M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $57.21M 10-Q · filed 2022-08-01 | $111.35M 10-Q · filed 2022-08-01 | $171.95M derived: sum of 3 quarters · filed 2023-02-22 | $230.82M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $54.14M 10-Q · filed 2022-05-05 | $114.74M derived: sum of 2 quarters · filed 2023-02-22 | $173.60M derived: sum of 3 quarters · filed 2023-02-22 | $226.88M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $60.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $119.46M derived: sum of 2 quarters · filed 2023-02-22 | $172.73M derived: sum of 3 quarters · filed 2023-02-22 | $221.03M 10-K · filed 2023-02-22 |
| 2020-09-30 | $58.87M 10-Q · filed 2021-10-28 | $112.14M derived: sum of 2 quarters · filed 2021-10-28 | $160.44M 10-Q · filed 2021-10-28 | $218.53M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $53.27M 10-Q · filed 2021-08-03 | $101.57M 10-Q · filed 2021-08-03 | $159.66M derived: sum of 3 quarters · filed 2022-02-11 | $218.08M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $48.30M 10-Q · filed 2021-04-29 | $106.39M derived: sum of 2 quarters · filed 2022-02-11 | $164.81M derived: sum of 3 quarters · filed 2022-02-11 | $218.42M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $58.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $116.51M derived: sum of 2 quarters · filed 2022-02-11 | $170.12M derived: sum of 3 quarters · filed 2022-02-11 | $210.31M 10-K · filed 2022-02-11 |
| 2019-09-30 | $58.42M 10-Q · filed 2020-10-29 | $112.02M derived: sum of 2 quarters · filed 2020-10-29 | $152.22M 10-Q · filed 2020-10-29 | $200.15M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $53.61M 10-Q · filed 2020-07-30 | $93.80M 10-Q · filed 2020-07-30 | $141.73M derived: sum of 3 quarters · filed 2021-02-12 | $181.86M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $40.20M 10-Q · filed 2020-05-05 | $88.13M derived: sum of 2 quarters · filed 2021-02-12 | $128.25M derived: sum of 3 quarters · filed 2021-02-12 | $167.30M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $47.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $88.06M derived: sum of 2 quarters · filed 2021-02-12 | $127.10M derived: sum of 3 quarters · filed 2021-02-12 | $173.65M 10-K · filed 2021-02-12 |
| 2018-09-30 | $40.13M 10-Q · filed 2019-11-07 | $79.17M derived: sum of 2 quarters · filed 2019-11-07 | $125.72M 10-Q · filed 2019-11-07 | $163.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $39.05M 10-Q · filed 2019-08-02 | $85.59M 10-Q · filed 2019-08-02 | $122.87M derived: sum of 3 quarters · filed 2020-02-21 | $165.31M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $46.54M 10-Q · filed 2019-05-07 | $83.83M derived: sum of 2 quarters · filed 2020-02-21 | $126.27M derived: sum of 3 quarters · filed 2020-02-21 | $160.89M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $37.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $79.72M derived: sum of 2 quarters · filed 2020-02-21 | $114.35M derived: sum of 3 quarters · filed 2020-02-21 | $166.94M 10-K · filed 2020-02-21 |
| 2017-09-30 | $42.44M 10-Q · filed 2018-11-07 | $77.07M derived: sum of 2 quarters · filed 2018-11-07 | $129.65M 10-Q · filed 2018-11-07 | $160.18M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $34.62M 10-Q · filed 2018-08-01 | $87.21M 10-Q · filed 2018-08-01 | $117.74M derived: sum of 3 quarters · filed 2019-02-22 | $158.61M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $52.59M 10-Q · filed 2018-05-03 | $83.11M derived: sum of 2 quarters · filed 2019-02-22 | $123.99M derived: sum of 3 quarters · filed 2019-02-22 | $165.26M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $30.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $71.40M derived: sum of 2 quarters · filed 2019-02-22 | $112.67M derived: sum of 3 quarters · filed 2019-02-22 | $153.40M 10-K · filed 2019-02-22 |
| 2016-09-30 | $40.88M 10-Q · filed 2017-11-07 | $82.15M derived: sum of 2 quarters · filed 2017-11-07 | $122.87M 10-Q · filed 2017-11-07 | $163.34M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $41.27M 10-Q · filed 2017-08-01 | $82.00M 10-Q · filed 2017-08-01 | $122.47M derived: sum of 3 quarters · filed 2018-02-23 | $167.90M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $40.73M 10-Q · filed 2017-05-02 | $81.20M derived: sum of 2 quarters · filed 2018-02-23 | $126.63M derived: sum of 3 quarters · filed 2018-02-23 | $163.93M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $40.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $85.91M derived: sum of 2 quarters · filed 2018-02-23 | $123.21M derived: sum of 3 quarters · filed 2018-02-23 | $157.68M 10-K · filed 2018-02-23 |
| 2015-09-30 | $45.44M 10-Q · filed 2016-11-02 | $82.73M derived: sum of 2 quarters · filed 2016-11-02 | $117.20M 10-Q · filed 2016-11-02 | $159.57M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $37.30M 10-Q · filed 2016-08-08 | $71.77M 10-Q · filed 2016-08-08 | $114.14M derived: sum of 3 quarters · filed 2017-02-24 | $149.80M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $34.47M 10-Q · filed 2016-05-04 | $76.84M derived: sum of 2 quarters · filed 2017-02-24 | $112.50M derived: sum of 3 quarters · filed 2017-02-24 | $146.24M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $42.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $78.03M derived: sum of 2 quarters · filed 2017-02-24 | $111.77M derived: sum of 3 quarters · filed 2017-02-24 | $140.22M 10-K · filed 2017-02-24 |
| 2014-09-30 | $35.66M 10-Q · filed 2015-11-05 | $69.40M derived: sum of 2 quarters · filed 2015-11-05 | $97.85M 10-Q · filed 2015-11-05 | $129.84M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $33.74M 10-Q · filed 2015-08-05 | $62.19M 10-Q · filed 2015-08-05 | $94.18M derived: sum of 3 quarters · filed 2016-02-26 | $127.39M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $28.45M 10-Q/A · filed 2015-05-08 | $60.44M derived: sum of 2 quarters · filed 2016-02-26 | $93.65M derived: sum of 3 quarters · filed 2016-02-26 | $122.63M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $65.20M derived: sum of 2 quarters · filed 2016-02-26 | $94.19M derived: sum of 3 quarters · filed 2016-02-26 | $123.75M 10-K · filed 2016-02-26 |
| 2013-09-30 | $33.21M 10-Q · filed 2014-11-06 | $62.19M derived: sum of 2 quarters · filed 2014-11-06 | $91.76M 10-Q · filed 2014-11-06 | $119.72M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $28.98M 10-Q · filed 2014-08-01 | $58.55M 10-Q · filed 2014-08-01 | $86.51M derived: sum of 3 quarters · filed 2015-02-26 | $114.34M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $29.57M 10-Q · filed 2014-05-02 | $57.53M derived: sum of 2 quarters · filed 2015-02-26 | $85.36M derived: sum of 3 quarters · filed 2015-02-26 | $110.03M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $27.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $55.79M derived: sum of 2 quarters · filed 2015-02-26 | $80.46M derived: sum of 3 quarters · filed 2015-02-26 | $105.22M 10-K · filed 2015-02-26 |
| 2012-09-30 | $27.83M 10-Q · filed 2013-11-06 | $52.50M derived: sum of 2 quarters · filed 2013-11-06 | $77.26M 10-Q · filed 2013-11-06 | $105.27M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $24.67M 10-Q · filed 2013-08-07 | $49.43M 10-Q · filed 2013-08-07 | $77.44M derived: sum of 3 quarters · filed 2014-02-21 | $103.92M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $24.76M 10-Q · filed 2013-05-09 | $52.77M derived: sum of 2 quarters · filed 2014-02-21 | $79.26M derived: sum of 3 quarters · filed 2014-02-21 | $99.91M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $28.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $54.49M derived: sum of 2 quarters · filed 2014-02-21 | $75.14M derived: sum of 3 quarters · filed 2014-02-21 | $95.39M 10-K · filed 2014-02-21 |
| 2011-09-30 | $26.48M 10-Q · filed 2012-10-31 | $47.13M derived: sum of 2 quarters · filed 2012-10-31 | $67.39M 10-Q · filed 2012-10-31 | |
| 2011-06-30 | $20.65M 10-Q · filed 2012-08-03 | $40.90M 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | $20.25M 10-Q · filed 2012-05-02 | |||
| 2010-12-31 | $78.54M 10-K · filed 2013-03-01 | |||
| 2009-12-31 | $57.08M 8-K · filed 2012-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |